With a market cap of $ 120 Billions, Amgen is the largest biotech company in the world ahead of Gilead Sciences.

Amgen is focused on six main areas: 1.Oncology/Hematology 2. Cardiovascular 3. Inflammation 4. Bone Health 5. Neuroscience 6. Nephrology

22% of sales come from Enbrel, 20% from Neulasta and 10% from Prolia.